|
|||||
|
|
Molecular Insight into Recognition of the CGRPR Complex by Migraine Prevention Therapy Aimovig (Erenumab) |
|
| Affiliation: | 1. Department of Therapeutic Discovery, Amgen Research, Amgen, Thousand Oaks, CA 91320, USA;2. Department of Neuroscience, Amgen Research, Amgen, Thousand Oaks, CA 91320, USA;3. Department of Therapeutic Discovery, Amgen Research, Amgen, San Francisco, CA 94080, USA;4. Department of Therapeutic Discovery, Amgen Research, Amgen, Burnaby, BC V5A 1V7, Canada |
| Abstract: |  |
| Keywords: | CGRPR erenumab migraine monoclonal antibodies GPCR CDR-H3 loop Aimovig |
| 本文献已被 ScienceDirect 等数据库收录！ | |